A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
More top news
The mother of murdered soldier Lee Rigby has criticised the Ministry of Defence, saying it failed to support her family.
Prince Charles and the Duchess of Cornwall have visited Manchester Arena, the site of a suicide bombing in May which left 22 people dead.
The royal will visit the site of the deadly attack at Manchester Arena as he remembers those killed and injured.